Charles River Laboratories International, Inc.
$281.67
$8.26 (+3.02%)
$274.40Day Range$285.58
Key Statistics
Market Cap
$13.05B
Shares Outstanding
47.7M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Jun 23, 2000
Round Lot
100
Locale
US
Trading Data
Day Open
$280.11
Day High
$285.58
Day Low
$274.40
Volume
809.8K
VWAP
$282.42
Prev Close
$273.41
Transactions
--
Acc. Volume
--
About Charles River Laboratories International, Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHSIC 873119,700 employees251 BALLARDVALE ST, WILMINGTON, MA, 01887781-222-6000IPO Jun 23, 2000US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001100682
- Composite FIGI
- BBG000BG5BL8
- Share Class FIGI
- BBG001S7Q271
- Ticker Root
- CRL
- SIC Code
- 8731
About Charles River Laboratories International, Inc. (CRL) Stock
Charles River Laboratories International, Inc. (CRL) closed the 2026-09-17 session at $281.67, up 3.02% versus the previous close (+8.26). The stock opened at $280.11 and traded between $274.40 and $285.58 during that session. Session trading volume was 810K shares. The volume-weighted average price (VWAP) is $282.42.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Charles River Laboratories International, Inc. has a market capitalization of $13.05 billion. The company operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry classification. CRL is listed on the XNYS exchange. The company employs approximately 19,700 people. Charles River Laboratories International, Inc. is headquartered in WILMINGTON, MA. The recorded listing date is 2000-06-23.
On this page you can find market CRL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.